{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T19:41:56Z","timestamp":1772134916843,"version":"3.50.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000297","name":"FRAXA Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000297","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["HD076189"],"award-info":[{"award-number":["HD076189"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013224","name":"National Fragile X Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013224","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007926","name":"University of Oklahoma","doi-asserted-by":"publisher","award":["Research Publication Subvention Funding Program"],"award-info":[{"award-number":["Research Publication Subvention Funding Program"]}],"id":[{"id":"10.13039\/100007926","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"DOI":"10.1038\/s41398-025-03558-2","type":"journal-article","created":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T07:26:52Z","timestamp":1756366012000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["ROC Analysis of Biomarker Combinations in Fragile X Syndrome-Specific Clinical Trials: Evaluating Treatment Efficacy via Exploratory Biomarkers"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4438-3416","authenticated-orcid":false,"given":"Jordan E.","family":"Norris","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth M.","family":"Berry-Kravis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark D.","family":"Harnett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott A.","family":"Reines","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melody R.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma K.","family":"Auger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abigail H.","family":"Outterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremiah","family":"Furman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark E.","family":"Gurney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0601-6911","authenticated-orcid":false,"given":"Lauren E.","family":"Ethridge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,28]]},"reference":[{"key":"3558_CR1","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1146\/annurev-pathol-011811-132457","volume":"7","author":"MR Santoro","year":"2021","unstructured":"Santoro MR, Bray SM, Warren ST. Molecular mechanisms of fragile X syndrome: a twenty-year perspective. Annu Rev Pathol. 2021;7:219\u201345. https:\/\/doi.org\/10.1146\/annurev-pathol-011811-132457.","journal-title":"Annu Rev Pathol"},{"key":"3558_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-29786-4","volume":"13","author":"D Straub","year":"2023","unstructured":"Straub D, Schmitt LM, Boggs AE, Horn PS, Dominick KC, Gross C, et al. A sensitive and reproducible qRT-PCR assay detects physiological relevant trace levels of FMR1 mRNA in individuals with Fragile X syndrome. Sci Rep. 2023;13:3808. https:\/\/doi.org\/10.1038\/s41598-023-29786-4.","journal-title":"Sci Rep"},{"key":"3558_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2020.104740","volume":"136","author":"MJ Salcedo-Arellano","year":"2020","unstructured":"Salcedo-Arellano MJ, Dufour B, McLennan Y, Martinez-Cerdeno V, Hagerman R. Fragile X syndrome and associated disorders: Clinical aspects and pathology. Neurobiol Dis. 2020;136:104740. https:\/\/doi.org\/10.1016\/j.nbd.2020.104740.","journal-title":"Neurobiol Dis"},{"key":"3558_CR4","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcz042","volume":"2","author":"LM Schmitt","year":"2020","unstructured":"Schmitt LM, Wang J, Pedapati EV, Thurman AJ, Abbeduto L, Erickson CA, et al. A neurophysiological model of speech production deficits in fragile X syndrome. Brain Commun. 2020;2:fcz042. https:\/\/doi.org\/10.1093\/braincomms\/fcz042.","journal-title":"Brain Commun"},{"key":"3558_CR5","doi-asserted-by":"publisher","first-page":"R273","DOI":"10.1016\/j.cub.2021.01.043","volume":"31","author":"PJ Hagerman","year":"2021","unstructured":"Hagerman PJ, Hagerman R. Fragile X syndrome. Curr Biol. 2021;31:R273\u2013R275. https:\/\/doi.org\/10.1016\/j.cub.2021.01.043.","journal-title":"Curr Biol"},{"key":"3558_CR6","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1007\/s10803-018-3796-2","volume":"49","author":"L Abbeduto","year":"2019","unstructured":"Abbeduto L, Thurman AJ, McDuffie A, Klusek J, Feigles RT, Brown TW, et al. ASD Comorbidity in Fragile X Syndrome: Symptom Profile and Predictors of Symptom Severity in Adolescent and Young Adult Males. J Autism Dev Disord. 2019;49:960\u201377. https:\/\/doi.org\/10.1007\/s10803-018-3796-2.","journal-title":"J Autism Dev Disord"},{"key":"3558_CR7","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1352\/1944-7558-127.1.64","volume":"127","author":"Thurman","year":"2022","unstructured":"Thurman, Swinehart AJ, Klusek SS, Roberts J, Bullard JE, Marzan L, et al. Daily Living Skills in Adolescent and Young Adult Males With Fragile X Syndrome. Am J Intellect Dev Disabil. 2022;127:64\u201383. https:\/\/doi.org\/10.1352\/1944-7558-127.1.64.","journal-title":"Am J Intellect Dev Disabil"},{"key":"3558_CR8","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.1007\/s10803-020-04367-w","volume":"50","author":"LV Usher","year":"2020","unstructured":"Usher LV, DaWalt LS, Hong J, Greenberg JS, Mailick MR. Trajectories of Change in the Behavioral and Health Phenotype of Adolescents and Adults with Fragile X Syndrome and Intellectual Disability: Longitudinal Trends Over a Decade. J Autism Dev Disord. 2020;50:2779\u201392. https:\/\/doi.org\/10.1007\/s10803-020-04367-w.","journal-title":"J Autism Dev Disord"},{"key":"3558_CR9","doi-asserted-by":"publisher","unstructured":"Weber JD, Smith E, Berry-Kravis E, Cadavid D, Hessl D, Erickson C Voice of People with Fragile X Syndrome and Their Families: Reports from a Survey on Treatment Priorities. Brain Sci, 2019;9. https:\/\/doi.org\/10.3390\/brainsci9020018.","DOI":"10.3390\/brainsci9020018"},{"key":"3558_CR10","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/nrd.2017.221","volume":"17","author":"EM Berry-Kravis","year":"2018","unstructured":"Berry-Kravis EM, Lindemann L, Jonch AE, Apostol G, Bear MF, Carpenter RL, et al. Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome. Nat Rev Drug Discov. 2018;17:280\u201399. https:\/\/doi.org\/10.1038\/nrd.2017.221.","journal-title":"Nat Rev Drug Discov"},{"key":"3558_CR11","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/s41591-021-01321-w","volume":"27","author":"EM Berry-Kravis","year":"2021","unstructured":"Berry-Kravis EM, Harnett MD, Reines SA, Reese MA, Ethridge LE, Outterson AH, et al. Inhibition of phosphodiesterase-4D in adults with fragile X syndrome: a randomized, placebo-controlled, phase 2 clinical trial. Nat Med. 2021;27:862\u201370. https:\/\/doi.org\/10.1038\/s41591-021-01321-w.","journal-title":"Nat Med"},{"key":"3558_CR12","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1203\/00006450-199511000-00002","volume":"38","author":"E Berry-Kravis","year":"1995","unstructured":"Berry-Kravis E, Hicar M, Ciurlionis R. Reduced cyclic AMP production in Fragile X Syndrome: cytogenetic and molecular correlations. Pediatric Res. 1995;38:638\u201343. 0031-3998\/95\/3805-0638$03.00\/0.","journal-title":"Pediatric Res"},{"key":"3558_CR13","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/(sici)1097-4547","volume":"51","author":"E Berry-Kravis","year":"1998","unstructured":"Berry-Kravis E. Overexpression of fragile X gene (FMR-1) transcripts increases cAMP production in neural cells. J Neurosci Res. 1998;51:41\u201348. https:\/\/doi.org\/10.1002\/(sici)1097-4547.","journal-title":"J Neurosci Res"},{"key":"3558_CR14","doi-asserted-by":"publisher","first-page":"13111","DOI":"10.1523\/JNEUROSCI.1347-12.2012","volume":"32","author":"AK Kanellopoulos","year":"2012","unstructured":"Kanellopoulos AK, Semelidou O, Kotini AG, Anezaki M, Skoulakis EM. Learning and memory deficits consequent to reduction of the fragile X mental retardation protein result from metabotropic glutamate receptor-mediated inhibition of cAMP signaling in Drosophila. J Neurosci. 2012;32:13111\u201324. https:\/\/doi.org\/10.1523\/JNEUROSCI.1347-12.2012.","journal-title":"J Neurosci"},{"key":"3558_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2016.48","volume":"6","author":"LE Ethridge","year":"2016","unstructured":"Ethridge LE, White SP, Mosconi MW, Wang J, Byerly MJ, Sweeney JA. Reduced habituation of auditory evoked potentials indicate cortical hyper-excitability in Fragile X Syndrome. Transl Psychiatry. 2016;6:e787. https:\/\/doi.org\/10.1038\/tp.2016.48.","journal-title":"Transl Psychiatry"},{"key":"3558_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s13229-024-00626-0","volume":"15","author":"JE Norris","year":"2024","unstructured":"Norris JE, Berry-Kravis EM, Harnett MD, et al. Auditory N1 event-related potential amplitude is predictive of serum concentration of BPN14770 in fragile X syndrome. Mol Autism. 2024;15:47. https:\/\/doi.org\/10.1186\/s13229-024-00626-0.","journal-title":"Mol Autism"},{"key":"3558_CR17","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/s42003-022-03395-9","volume":"5","author":"EV Pedapati","year":"2022","unstructured":"Pedapati EV, Schmitt LM, Ethridge LE, Miyakoshi M, Sweeney JA, et al. Neocortical localization and thalamocortical modulation of neuronal hyperexcitability contribute to Fragile X Syndrome. Commun Biol. 2022;5:442 https:\/\/doi.org\/10.1038\/s42003-022-03395-9.","journal-title":"Commun Biol"},{"key":"3558_CR18","doi-asserted-by":"publisher","unstructured":"Wang J, Ethridge LE, Mosconi MW, White SP, Binder DK, Pedapati EV, et al. A resting EEG study of neocortical hyperexcitability and altered functional connectivity in fragile X syndrome. J Neurodev Disord. 2017;9. https:\/\/doi.org\/10.1186\/s11689-017-9191-z.","DOI":"10.1186\/s11689-017-9191-z"},{"key":"3558_CR19","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1080\/13854040600744839","volume":"21","author":"E Angelakis","year":"2007","unstructured":"Angelakis E, Stathopoulou S, Frymiare JL, Green DL, Lubar JF, Kounios J. EEG neurofeedback: a brief overview and an example of peak alpha frequency training for cognitive enhancement in the elderly. Clin Neuropsychol. 2007;21:110\u201329. https:\/\/doi.org\/10.1080\/13854040600744839.","journal-title":"Clin Neuropsychol"},{"key":"3558_CR20","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.1021\/acschemneuro.2c00404","volume":"13","author":"JE Norris","year":"2022","unstructured":"Norris JE, DeStefano LA, Schmitt LM, Pedapati EV, Erickson CA, Sweeney JA. Hemispheric Utilization of Alpha Oscillatory Dynamics as a Unique Biomarker of Neural Compensation in Females with Fragile X Syndrome. ACS Chem Neurosci. 2022;13:3389\u2013402. https:\/\/doi.org\/10.1021\/acschemneuro.2c00404.","journal-title":"ACS Chem Neurosci"},{"key":"3558_CR21","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1055\/s-0040-1712585","volume":"11","author":"S Rathee","year":"2020","unstructured":"Rathee S, Bhatia D, Punia V, Singh R. Peak Alpha Frequency in Relation to Cognitive Performance. J Neurosci Rural Pr. 2020;11:416\u20139. https:\/\/doi.org\/10.1055\/s-0040-1712585.","journal-title":"J Neurosci Rural Pr"},{"key":"3558_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpsycho.2003.12.011","volume":"53","author":"C Richard Clark","year":"2004","unstructured":"Richard Clark C, Veltmeyer MD, Hamilton RJ, et al. Spontaneous alpha peak frequency predicts working memory performance across the age span. Int J Psychophysiol. 2004;53:1\u20139. https:\/\/doi.org\/10.1016\/j.ijpsycho.2003.12.011.","journal-title":"Int J Psychophysiol"},{"key":"3558_CR23","doi-asserted-by":"publisher","DOI":"10.1111\/psyp.14586","volume":"61","author":"N Busch","year":"2024","unstructured":"Busch N, Geyer T, Zinchenko A. Individual peak alpha frequency does not index individual differences in inhibitory cognitive control. Psychophysiology. 2024;61:e14586. https:\/\/doi.org\/10.1111\/psyp.14586.","journal-title":"Psychophysiology"},{"key":"3558_CR24","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.conctc.2018.08.001","volume":"11","author":"DB Fogel","year":"2018","unstructured":"Fogel DB. Factors associated with clinical trials that fail and opportunities for improving the likelihood of success: A review. Contemp Clin Trials Commun. 2018;11:156\u201364. https:\/\/doi.org\/10.1016\/j.conctc.2018.08.001.","journal-title":"Contemp Clin Trials Commun"},{"key":"3558_CR25","doi-asserted-by":"publisher","unstructured":"Hsu M-J, Chang Y-CI, Hsueh H-M Biomarker selection for medical diagnosis using the partial area under the ROC curve. BMC Research Notes, 2014;7. https:\/\/doi.org\/10.1186\/1756-0500-7-25.","DOI":"10.1186\/1756-0500-7-25"},{"key":"3558_CR26","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.acra.2013.03.009","volume":"20","author":"D Liu","year":"2013","unstructured":"Liu D, Zhou XH. ROC analysis in biomarker combination with covariate adjustment. Acad Radio. 2013;20:874\u201382. https:\/\/doi.org\/10.1016\/j.acra.2013.03.009.","journal-title":"Acad Radio"},{"key":"3558_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-72935-6","volume":"14","author":"LE Ethridge","year":"2024","unstructured":"Ethridge LE, Pedapati EV, Schmitt LM, et al. Validating brain activity measures as reliable indicators of individual diagnostic group and genetically mediated sub-group membership Fragile X Syndrome. Sci Rep. 2024;14:22982. https:\/\/doi.org\/10.1038\/s41598-024-72935-6. Published 2024 Oct 3.","journal-title":"Sci Rep"},{"key":"3558_CR28","doi-asserted-by":"publisher","first-page":"541","DOI":"10.3390\/healthcare10030541","volume":"10","author":"MM Ahsan","year":"2022","unstructured":"Ahsan MM, Luna SA, Siddique Z. Machine-Learning-Based Disease Diagnosis: A Comprehensive Review. Healthcare (Basel). 2022;10:541 https:\/\/doi.org\/10.3390\/healthcare10030541.","journal-title":"Healthcare (Basel)"},{"key":"3558_CR29","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jneumeth.2003.10.009","volume":"134","author":"A Delorme","year":"2004","unstructured":"Delorme A, Makeig S. EEGLAB: an open source toolbox for analysis of single-trial EEG dynamics including independent component analysis. J Neurosci Methods. 2004;134:9\u201321. https:\/\/doi.org\/10.1016\/j.jneumeth.2003.10.009.","journal-title":"J Neurosci Methods"},{"key":"3558_CR30","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3389\/fnhum.2010.00232","volume":"4","author":"JJB Allen","year":"2010","unstructured":"Allen JJB, Cohen MX. Deconstructing the \u201cresting\u201d state: exploring the temporal dynamics of frontal alpha asymmetry as an endophenotype for depression. Front Hum Neurosci. 2010;4:232 https:\/\/doi.org\/10.3389\/fnhum.2010.00232.","journal-title":"Front Hum Neurosci"},{"key":"3558_CR31","doi-asserted-by":"publisher","unstructured":"Sordo M, Zeng Q On Sample Size and Classification Accuracy: A Performance Comparison. In: Oliveira, JL, Maojo, V, Mart\u00edn-S\u00e1nchez, F, Pereira, AS (eds) Biological and Medical Data Analysis. ISBMDA 2005. Lecture Notes in Computer Science, 2005;3745:193-201. https:\/\/doi.org\/10.1007\/11573067_20.","DOI":"10.1007\/11573067_20"},{"key":"3558_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-11-447","volume":"11","author":"Y Guo","year":"2010","unstructured":"Guo Y, Graber A, McBurney RN, Balasubramanian R. Sample size and statistical power considerations in high-dimensionality data settings: a comparative study of classification algorithms. BMC Bioinforma. 2010;11:447. https:\/\/doi.org\/10.1186\/1471-2105-11-447.","journal-title":"BMC Bioinforma"},{"key":"3558_CR33","doi-asserted-by":"publisher","first-page":"S54","DOI":"10.1212\/WNL.0b013e3182872ded","volume":"80","author":"S Weintraub","year":"2013","unstructured":"Weintraub S, Dikmen SS, Heaton RK, Tulsky DS, Zelazo PD, Bauer PJ, et al. Cognition assessment using the NIH Toolbox. Neurology. 2013;80:S54\u201364. https:\/\/doi.org\/10.1212\/WNL.0b013e3182872ded.","journal-title":"Neurology"},{"key":"3558_CR34","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1037\/t10453-000","volume":"89","author":"MG Aman","year":"1985","unstructured":"Aman MG, Singh NN, Stewart AW, Field CJ. The Aberrant Behavior Checklist: a behavior rating scale for the assessment of treatment effects. Am J Ment Defic. 1985;89:485\u201391. https:\/\/doi.org\/10.1037\/t10453-000.","journal-title":"Am J Ment Defic"},{"key":"3558_CR35","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1023\/b:jadd.0000005999.27178.55","volume":"33","author":"AJ Esbensen","year":"2003","unstructured":"Esbensen AJ, Rojahn J, Aman MG, Ruedrich S. Reliability and validity of an assessment instrument for anxiety, depression, and mood among individuals with mental retardation. J Autism Dev Disord. 2003;33:617\u201329. https:\/\/doi.org\/10.1023\/b:jadd.0000005999.27178.55.","journal-title":"J Autism Dev Disord"},{"key":"3558_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.dcn.2021.100969","volume":"50","author":"D Cellier","year":"2021","unstructured":"Cellier D, Riddle J, Petersen I, Hwang K. The development of theta and alpha neural oscillations from ages 3 to 24 years. Dev Cogn Neurosci. 2021;50:100969. https:\/\/doi.org\/10.1016\/j.dcn.2021.100969.","journal-title":"Dev Cogn Neurosci"},{"key":"3558_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.716707","volume":"12","author":"M Proteau-Lemieux","year":"2021","unstructured":"Proteau-Lemieux M, Knoth IS, Agbogba K, Cote V, Barlahan Biag HM, Thurman AJ, et al. EEG Signal Complexity Is Reduced During Resting-State in Fragile X Syndrome. Front Psychiatry. 2021;12:716707. https:\/\/doi.org\/10.3389\/fpsyt.2021.716707.","journal-title":"Front Psychiatry"},{"key":"3558_CR38","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s11689-022-09438-w","volume":"14","author":"C Gupta","year":"2022","unstructured":"Gupta C, Chandrashekar P, Jin T, He C, Khullar S, Chang Q, et al. Bringing machine learning to research on intellectual and developmental disabilities: taking inspiration from neurological diseases. J Neurodev Disord. 2022;14:28 https:\/\/doi.org\/10.1186\/s11689-022-09438-w.","journal-title":"J Neurodev Disord"},{"key":"3558_CR39","doi-asserted-by":"publisher","first-page":"25","DOI":"10.4097\/kja.21209","volume":"75","author":"FS Nahm","year":"2022","unstructured":"Nahm FS. Receiver operating characteristic curve: overview and practical use for clinicians. Korean J Anesthesiol. 2022;75:25\u201336. https:\/\/doi.org\/10.4097\/kja.21209.","journal-title":"Korean J Anesthesiol"},{"key":"3558_CR40","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.clinph.2003.11.034","volume":"115","author":"E Angelakis","year":"2004","unstructured":"Angelakis E, Lubar JF, Stathopoulou S, Kounios J. Peak alpha frequency: an electroencephalographic measure of cognitive preparedness. Clin Neurophysiol. 2004;115:887\u201397. https:\/\/doi.org\/10.1016\/j.clinph.2003.11.034.","journal-title":"Clin Neurophysiol"},{"key":"3558_CR41","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1111\/ejn.13645","volume":"47","author":"A Dickinson","year":"2018","unstructured":"Dickinson A, DiStefano C, Senturk D, Jeste SS. Peak alpha frequency is a neural marker of cognitive function across the autism spectrum. Eur J Neurosci. 2018;47:643\u201351. https:\/\/doi.org\/10.1111\/ejn.13645.","journal-title":"Eur J Neurosci"},{"key":"3558_CR42","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1111\/psyp.12043","volume":"50","author":"TH Grandy","year":"2013","unstructured":"Grandy TH, Werkle-Bergner M, Chicherio C, Schmiedek F, L\u00f6vd\u00e9n M, Lindenberger U. Peak individual alpha frequency qualifies as a stable neurophysiological trait marker in healthy younger and older adults. Psychophysiology. 2013;50:570\u201382. https:\/\/doi.org\/10.1111\/psyp.12043.","journal-title":"Psychophysiology"},{"key":"3558_CR43","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.neuroscience.2017.07.037","volume":"360","author":"A Mierau","year":"2017","unstructured":"Mierau A, Klimesch W, Lefebvre J. State-dependent alpha peak frequency shifts: Experimental evidence, potential mechanisms and functional implications. Neuroscience. 2017;360:146\u201354. https:\/\/doi.org\/10.1016\/j.neuroscience.2017.07.037.","journal-title":"Neuroscience"},{"key":"3558_CR44","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3389\/fnint.2019.00060","volume":"13","author":"LE Ethridge","year":"2019","unstructured":"Ethridge LE, De Stefano LA, Schmitt LM, Woodruff NE, Brown KL, Tran M, et al. Auditory EEG Biomarkers in Fragile X Syndrome: Clinical Relevance. Front Integr Neurosci. 2019;13:60 https:\/\/doi.org\/10.3389\/fnint.2019.00060.","journal-title":"Front Integr Neurosci"},{"key":"3558_CR45","doi-asserted-by":"publisher","unstructured":"Lewis, DD Naive (Bayes) at forty: The independence assumption in information retrieval. In: N\u00e9dellec, C, Rouveirol, C (eds) Machine Learning: ECML-98. Lecture Notes in Computer Science, vol 1398. 1998; Springer, Berlin, Heidelberg. https:\/\/doi.org\/10.1007\/BFb0026666.","DOI":"10.1007\/BFb0026666"},{"key":"3558_CR46","unstructured":"Sordo M & Zeng Q in Biological and Medical Data Analysis. (eds Oliveira Jos\u00e9 Lu\u00eds, Maojo V\u00edctor, Mart\u00edn-S\u00e1nchez Fernando, & Pereira Ant\u00f3nio Sousa) 193\u2013201 (Springer; Berlin Heidelberg:)."}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-025-03558-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-025-03558-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-025-03558-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T19:59:44Z","timestamp":1757447984000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-025-03558-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,28]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3558"],"URL":"https:\/\/doi.org\/10.1038\/s41398-025-03558-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.05.29.25328581","asserted-by":"object"}]},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,28]]},"assertion":[{"value":"16 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"E.M.B.-K., M.R.S., E.K.A., A.O., C.M. and J.F. declare no competing interests. M.D.H. and S.A.R. are paid consultants to Tetra Therapeutics. M.E.G. is an employee of Tetra. Therapeutics, which is a wholly owned subsidiary of Shionogi & Company that has a financial interest in BPN14770. J.E.N, and L.E.E. received research funding from Shionogi & Company for independent data analysis; all funds are contracted to and managed by the University of Oklahoma.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"323"}}